This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
The 1st Real World Evidence Study on IDegAsp in Saudi Arabia

ARISE is a prospective, multi-centre, open-label,non-interventional, single-arm study of Ryzodeg® in patients with T2D aiming to assess glycaemic control and other clinical parameters in real-world settings across six countries. 

UPDATES is a prospective non-interventional study investigating the treatment effect of Tresiba® in adult patients with type 2 diabetes in Saudi Arabia.